Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/01/2007WO2007122402A1 Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases
11/01/2007WO2007122280A1 Use of the liver growth factor (lgf) as pleiotropic tissue regenerator
11/01/2007WO2007122213A2 Means and methods for diagnosing and treating cancer based on the frmd3 gene
11/01/2007WO2007122187A2 Use of fungal polysaccharides as pharmaceutical composition or food complements
11/01/2007WO2007122179A1 Hydrolysate of avian cartilage, process of preparation and uses thereof
11/01/2007WO2007121807A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007WO2007121576A1 Methods of inducing apoptosis of cancerous cells using apoptin derivatives
11/01/2007WO2007121546A1 Use of mas-g-protein-coupled receptor agonists in the treatment of the metabolic syndrome, its components and its complications
11/01/2007WO2007121538A1 Anti-inflammatory blood product and method of use
11/01/2007WO2007121491A1 Hcv vaccinations
11/01/2007WO2007106488A3 Modulators of gluconeogenesis
11/01/2007WO2007104567A3 Pegylated mutated clostridium botulinum toxin
11/01/2007WO2007103765A3 Treatment with cyclosporin a
11/01/2007WO2007101988A3 Use of tsg-6 for treating bone diseases
11/01/2007WO2007101222A3 Cancer treatment
11/01/2007WO2007098945A3 Stable solid dosage form comprising desmopressin
11/01/2007WO2007097980A9 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
11/01/2007WO2007095057A3 Use of eap protein for treating and preventing autoimmune neuroinflammatory diseases
11/01/2007WO2007084954A3 Selective inhibition of ig20 splice variants to treat cancers
11/01/2007WO2007081949A3 Small-volume oral transmucosal dosage forms
11/01/2007WO2007075899A8 Dual agonist compounds and uses thereof
11/01/2007WO2007074457A3 Histidine-containing diastereomeric peptides and uses thereof
11/01/2007WO2007033369A3 Assessing risk of cerebrovascular thrombosis by measuring c4d on platelets
11/01/2007WO2007008376A3 Use of one or more metal carriers to selectively kill mammalian cells
11/01/2007WO2006136454A3 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
11/01/2007WO2006135738A3 Devices from prion-like proteins
11/01/2007WO2006083183A9 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting)
11/01/2007WO2006083182A9 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease
11/01/2007WO2006076225A3 Methods and systems for identifying and monitoring s-nitrosothiols in biological samples
11/01/2007WO2005121330A3 Isolated chimeric proteins of modified lumazine synthase
11/01/2007WO2005004795A3 Compositions and methods for targeted drug delivery
11/01/2007WO2004032622A8 Production of peptides in plants as viral coat protein fusions
11/01/2007WO2003105886A3 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
11/01/2007WO2003092632A3 Cyclic peptide anti-cancer agents and methods
11/01/2007WO2002064619A3 Peptides that inhibit poly-glutamine aggregation
11/01/2007WO2002060471A3 Ligands for receptor-like protein tyrosine phosphatases
11/01/2007US20070255044 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254846 stimulating T-cell transformation; cell proliferative disorder, anti-cancer, and/or anti-sarcoma
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254843 Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitors
11/01/2007US20070254842 Administration of growth factors for the treatment of cns disorders
11/01/2007US20070254841 Formulations and methods for treating dry eye
11/01/2007US20070254840 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides
11/01/2007US20070254839 Orally administered peptides synergize statin activity
11/01/2007US20070254838 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/01/2007US20070254837 Treatment for Necrotizing Enterocolitis
11/01/2007US20070254836 Glycopegylated Granulocyte Colony Stimulating Factor
11/01/2007US20070254835 Composition and method for treating neurological disorders
11/01/2007US20070254834 Glycopegylated Erythropoietin
11/01/2007US20070254833 Compositions and methods for treating diverticular disease
11/01/2007US20070254832 Methods for the treatment of macular degeneration and related eye conditions
11/01/2007US20070254829 Compound Ws727713
11/01/2007US20070254828 Pharmaceutical composition with healing activity comprising at least one soluble dextran derivative and at least one platelet-derived growth factor
11/01/2007US20070254364 Methods and compositions for treating disorders involving excitotoxicity
11/01/2007US20070254360 Expression vector comprising nucleotide sequences coding dorsal-ventral patterning fusion protein for use as tool in enhancement of immune response in infected cells
11/01/2007US20070254357 Gene therapy using replication competent targeted adenoviral vectors
11/01/2007US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007US20070254314 Methods of treating autism and autism spectrum disorders
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
11/01/2007US20070254287 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)
11/01/2007US20070254283 Brhf1 as a Cancer Diagnostic Marker
11/01/2007US20070254046 such as 4-Aminomethyl-N-[4-(5-biphenyl-4-yl-pyrazolo[1,5-c]pyrimidin-7-ylamino)-phenyl]-benzamide, useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis
11/01/2007US20070254040 Nutritional supplement and use thereof
11/01/2007US20070254038 Microspheroidal Controlled Release Of Biomolecules
11/01/2007US20070254021 liposomes; prevents signs of aging, improves aesthetic appearance of skin, and promotes recovery from environmental stresses; extracts from rosemary, Centella, Echinacea, Alpinia
11/01/2007US20070254020 Molecular communication system and molecular communication method
11/01/2007US20070254014 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
11/01/2007US20070254006 Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides
11/01/2007US20070253998 Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain
11/01/2007US20070253997 Drug delivery to alleviate chronic pelvic pain
11/01/2007US20070253994 Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
11/01/2007US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007US20070253968 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253959 Vascular endothelial cell growth factor antagonists
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253949 Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
11/01/2007US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007US20070253944 Use of creatine or creatine compounds for skin preservation
11/01/2007US20070253943 Compositions for Topical Treatment
11/01/2007US20070253942 Lectin-directed prodrug delivery system
11/01/2007US20070253941 Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
11/01/2007US20070253933 Carotene Synthase Gene and Uses Therefor
11/01/2007US20070253932 Recombinant adenoviral vectors and methods of use
11/01/2007US20070253930 Pharmaceutical removal of vascular and/or neuronal extensions form a degenerating disc
11/01/2007US20070253928 Pharmaceutical removal of neuronal extensions from a degenerating disc
11/01/2007US20070253912 Process for the preparation of micronised collagen, and its therapeutic applications
11/01/2007US20070253906 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
11/01/2007US20070253902 Treatment for inflammatory bowel disease
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007US20070252295 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 8; pH-sensitive liposomes comprise, in particular, cholesterol hemisuccinate
11/01/2007CA2800389A1 Glp-1 compounds
11/01/2007CA2652759A1 Nanoparticles for providing immune responses against infectious agents
11/01/2007CA2650229A1 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
11/01/2007CA2649960A1 Use of fungal polysaccharides as pharmaceutical composition or food complements for human or animal health
1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 3163